Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Metabotropic Glutamate Receptor 2 Market Growth 2022-2028

  • LP 4929828
  • 95 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Metabotropic Glutamate Receptor 2 will have significant change from previous year. According to our (LP Information) latest study, the global Metabotropic Glutamate Receptor 2 market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Metabotropic Glutamate Receptor 2 market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Metabotropic Glutamate Receptor 2 market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Metabotropic Glutamate Receptor 2 market, reaching US$ million by the year 2028. As for the Europe Metabotropic Glutamate Receptor 2 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Metabotropic Glutamate Receptor 2 players cover Addex Therapeutics Ltd, Bristol-Myers Squibb Company, Denovo Biopharma LLC, and Domain Therapeutics SA, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Metabotropic Glutamate Receptor 2 market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

LY-2607540

BMT-133218

DT-2442

JNJ-40411813

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Anxiety Disorders

Depression

Schizophrenia

Chronic Pain

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Addex Therapeutics Ltd

Bristol-Myers Squibb Company

Denovo Biopharma LLC

Domain Therapeutics SA

Eli Lilly and Company

Johnson & Johnson

Merck & Co Inc

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Metabotropic Glutamate Receptor 2 Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Metabotropic Glutamate Receptor 2 by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Metabotropic Glutamate Receptor 2 by Country/Region, 2017, 2022 & 2028

2.2 Metabotropic Glutamate Receptor 2 Segment by Type

2.2.1 LY-2607540

2.2.2 BMT-133218

2.2.3 DT-2442

2.2.4 JNJ-40411813

2.2.5 Others

2.3 Metabotropic Glutamate Receptor 2 Sales by Type

2.3.1 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2017-2022)

2.3.2 Global Metabotropic Glutamate Receptor 2 Revenue and Market Share by Type (2017-2022)

2.3.3 Global Metabotropic Glutamate Receptor 2 Sale Price by Type (2017-2022)

2.4 Metabotropic Glutamate Receptor 2 Segment by Application

2.4.1 Anxiety Disorders

2.4.2 Depression

2.4.3 Schizophrenia

2.4.4 Chronic Pain

2.4.5 Others

2.5 Metabotropic Glutamate Receptor 2 Sales by Application

2.5.1 Global Metabotropic Glutamate Receptor 2 Sale Market Share by Application (2017-2022)

2.5.2 Global Metabotropic Glutamate Receptor 2 Revenue and Market Share by Application (2017-2022)

2.5.3 Global Metabotropic Glutamate Receptor 2 Sale Price by Application (2017-2022)

3 Global Metabotropic Glutamate Receptor 2 by Company

3.1 Global Metabotropic Glutamate Receptor 2 Breakdown Data by Company

3.1.1 Global Metabotropic Glutamate Receptor 2 Annual Sales by Company (2020-2022)

3.1.2 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Company (2020-2022)

3.2 Global Metabotropic Glutamate Receptor 2 Annual Revenue by Company (2020-2022)

3.2.1 Global Metabotropic Glutamate Receptor 2 Revenue by Company (2020-2022)

3.2.2 Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Company (2020-2022)

3.3 Global Metabotropic Glutamate Receptor 2 Sale Price by Company

3.4 Key Manufacturers Metabotropic Glutamate Receptor 2 Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Metabotropic Glutamate Receptor 2 Product Location Distribution

3.4.2 Players Metabotropic Glutamate Receptor 2 Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Metabotropic Glutamate Receptor 2 by Geographic Region

4.1 World Historic Metabotropic Glutamate Receptor 2 Market Size by Geographic Region (2017-2022)

4.1.1 Global Metabotropic Glutamate Receptor 2 Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Metabotropic Glutamate Receptor 2 Annual Revenue by Geographic Region

4.2 World Historic Metabotropic Glutamate Receptor 2 Market Size by Country/Region (2017-2022)

4.2.1 Global Metabotropic Glutamate Receptor 2 Annual Sales by Country/Region (2017-2022)

4.2.2 Global Metabotropic Glutamate Receptor 2 Annual Revenue by Country/Region

4.3 Americas Metabotropic Glutamate Receptor 2 Sales Growth

4.4 APAC Metabotropic Glutamate Receptor 2 Sales Growth

4.5 Europe Metabotropic Glutamate Receptor 2 Sales Growth

4.6 Middle East & Africa Metabotropic Glutamate Receptor 2 Sales Growth

5 Americas

5.1 Americas Metabotropic Glutamate Receptor 2 Sales by Country

5.1.1 Americas Metabotropic Glutamate Receptor 2 Sales by Country (2017-2022)

5.1.2 Americas Metabotropic Glutamate Receptor 2 Revenue by Country (2017-2022)

5.2 Americas Metabotropic Glutamate Receptor 2 Sales by Type

5.3 Americas Metabotropic Glutamate Receptor 2 Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Metabotropic Glutamate Receptor 2 Sales by Region

6.1.1 APAC Metabotropic Glutamate Receptor 2 Sales by Region (2017-2022)

6.1.2 APAC Metabotropic Glutamate Receptor 2 Revenue by Region (2017-2022)

6.2 APAC Metabotropic Glutamate Receptor 2 Sales by Type

6.3 APAC Metabotropic Glutamate Receptor 2 Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Metabotropic Glutamate Receptor 2 by Country

7.1.1 Europe Metabotropic Glutamate Receptor 2 Sales by Country (2017-2022)

7.1.2 Europe Metabotropic Glutamate Receptor 2 Revenue by Country (2017-2022)

7.2 Europe Metabotropic Glutamate Receptor 2 Sales by Type

7.3 Europe Metabotropic Glutamate Receptor 2 Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Metabotropic Glutamate Receptor 2 by Country

8.1.1 Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Country (2017-2022)

8.1.2 Middle East & Africa Metabotropic Glutamate Receptor 2 Revenue by Country (2017-2022)

8.2 Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Type

8.3 Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Metabotropic Glutamate Receptor 2

10.3 Manufacturing Process Analysis of Metabotropic Glutamate Receptor 2

10.4 Industry Chain Structure of Metabotropic Glutamate Receptor 2

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Metabotropic Glutamate Receptor 2 Distributors

11.3 Metabotropic Glutamate Receptor 2 Customer

12 World Forecast Review for Metabotropic Glutamate Receptor 2 by Geographic Region

12.1 Global Metabotropic Glutamate Receptor 2 Market Size Forecast by Region

12.1.1 Global Metabotropic Glutamate Receptor 2 Forecast by Region (2023-2028)

12.1.2 Global Metabotropic Glutamate Receptor 2 Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Metabotropic Glutamate Receptor 2 Forecast by Type

12.7 Global Metabotropic Glutamate Receptor 2 Forecast by Application

13 Key Players Analysis

13.1 Addex Therapeutics Ltd

13.1.1 Addex Therapeutics Ltd Company Information

13.1.2 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Product Offered

13.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Addex Therapeutics Ltd Main Business Overview

13.1.5 Addex Therapeutics Ltd Latest Developments

13.2 Bristol-Myers Squibb Company

13.2.1 Bristol-Myers Squibb Company Company Information

13.2.2 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Product Offered

13.2.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Bristol-Myers Squibb Company Main Business Overview

13.2.5 Bristol-Myers Squibb Company Latest Developments

13.3 Denovo Biopharma LLC

13.3.1 Denovo Biopharma LLC Company Information

13.3.2 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Product Offered

13.3.3 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Denovo Biopharma LLC Main Business Overview

13.3.5 Denovo Biopharma LLC Latest Developments

13.4 Domain Therapeutics SA

13.4.1 Domain Therapeutics SA Company Information

13.4.2 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Product Offered

13.4.3 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Domain Therapeutics SA Main Business Overview

13.4.5 Domain Therapeutics SA Latest Developments

13.5 Eli Lilly and Company

13.5.1 Eli Lilly and Company Company Information

13.5.2 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Product Offered

13.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Eli Lilly and Company Main Business Overview

13.5.5 Eli Lilly and Company Latest Developments

13.6 Johnson & Johnson

13.6.1 Johnson & Johnson Company Information

13.6.2 Johnson & Johnson Metabotropic Glutamate Receptor 2 Product Offered

13.6.3 Johnson & Johnson Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Johnson & Johnson Main Business Overview

13.6.5 Johnson & Johnson Latest Developments

13.7 Merck & Co Inc

13.7.1 Merck & Co Inc Company Information

13.7.2 Merck & Co Inc Metabotropic Glutamate Receptor 2 Product Offered

13.7.3 Merck & Co Inc Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Merck & Co Inc Main Business Overview

13.7.5 Merck & Co Inc Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Metabotropic Glutamate Receptor 2 Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Metabotropic Glutamate Receptor 2 Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of LY-2607540

Table 4. Major Players of BMT-133218

Table 5. Major Players of DT-2442

Table 6. Major Players of JNJ-40411813

Table 7. Major Players of Others

Table 8. Global Metabotropic Glutamate Receptor 2 Sales by Type (2017-2022) & (K Pcs)

Table 9. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2017-2022)

Table 10. Global Metabotropic Glutamate Receptor 2 Revenue by Type (2017-2022) & ($ million)

Table 11. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Type (2017-2022)

Table 12. Global Metabotropic Glutamate Receptor 2 Sale Price by Type (2017-2022) & (USD/Pcs)

Table 13. Global Metabotropic Glutamate Receptor 2 Sales by Application (2017-2022) & (K Pcs)

Table 14. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2017-2022)

Table 15. Global Metabotropic Glutamate Receptor 2 Revenue by Application (2017-2022)

Table 16. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Application (2017-2022)

Table 17. Global Metabotropic Glutamate Receptor 2 Sale Price by Application (2017-2022) & (USD/Pcs)

Table 18. Global Metabotropic Glutamate Receptor 2 Sales by Company (2020-2022) & (K Pcs)

Table 19. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Company (2020-2022)

Table 20. Global Metabotropic Glutamate Receptor 2 Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Company (2020-2022)

Table 22. Global Metabotropic Glutamate Receptor 2 Sale Price by Company (2020-2022) & (USD/Pcs)

Table 23. Key Manufacturers Metabotropic Glutamate Receptor 2 Producing Area Distribution and Sales Area

Table 24. Players Metabotropic Glutamate Receptor 2 Products Offered

Table 25. Metabotropic Glutamate Receptor 2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Metabotropic Glutamate Receptor 2 Sales by Geographic Region (2017-2022) & (K Pcs)

Table 29. Global Metabotropic Glutamate Receptor 2 Sales Market Share Geographic Region (2017-2022)

Table 30. Global Metabotropic Glutamate Receptor 2 Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Metabotropic Glutamate Receptor 2 Sales by Country/Region (2017-2022) & (K Pcs)

Table 33. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Country/Region (2017-2022)

Table 34. Global Metabotropic Glutamate Receptor 2 Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Metabotropic Glutamate Receptor 2 Sales by Country (2017-2022) & (K Pcs)

Table 37. Americas Metabotropic Glutamate Receptor 2 Sales Market Share by Country (2017-2022)

Table 38. Americas Metabotropic Glutamate Receptor 2 Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Metabotropic Glutamate Receptor 2 Revenue Market Share by Country (2017-2022)

Table 40. Americas Metabotropic Glutamate Receptor 2 Sales by Type (2017-2022) & (K Pcs)

Table 41. Americas Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2017-2022)

Table 42. Americas Metabotropic Glutamate Receptor 2 Sales by Application (2017-2022) & (K Pcs)

Table 43. Americas Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2017-2022)

Table 44. APAC Metabotropic Glutamate Receptor 2 Sales by Region (2017-2022) & (K Pcs)

Table 45. APAC Metabotropic Glutamate Receptor 2 Sales Market Share by Region (2017-2022)

Table 46. APAC Metabotropic Glutamate Receptor 2 Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Metabotropic Glutamate Receptor 2 Revenue Market Share by Region (2017-2022)

Table 48. APAC Metabotropic Glutamate Receptor 2 Sales by Type (2017-2022) & (K Pcs)

Table 49. APAC Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2017-2022)

Table 50. APAC Metabotropic Glutamate Receptor 2 Sales by Application (2017-2022) & (K Pcs)

Table 51. APAC Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2017-2022)

Table 52. Europe Metabotropic Glutamate Receptor 2 Sales by Country (2017-2022) & (K Pcs)

Table 53. Europe Metabotropic Glutamate Receptor 2 Sales Market Share by Country (2017-2022)

Table 54. Europe Metabotropic Glutamate Receptor 2 Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Metabotropic Glutamate Receptor 2 Revenue Market Share by Country (2017-2022)

Table 56. Europe Metabotropic Glutamate Receptor 2 Sales by Type (2017-2022) & (K Pcs)

Table 57. Europe Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2017-2022)

Table 58. Europe Metabotropic Glutamate Receptor 2 Sales by Application (2017-2022) & (K Pcs)

Table 59. Europe Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Country (2017-2022) & (K Pcs)

Table 61. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Metabotropic Glutamate Receptor 2 Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Metabotropic Glutamate Receptor 2 Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Type (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Application (2017-2022) & (K Pcs)

Table 67. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Metabotropic Glutamate Receptor 2

Table 69. Key Market Challenges & Risks of Metabotropic Glutamate Receptor 2

Table 70. Key Industry Trends of Metabotropic Glutamate Receptor 2

Table 71. Metabotropic Glutamate Receptor 2 Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Metabotropic Glutamate Receptor 2 Distributors List

Table 74. Metabotropic Glutamate Receptor 2 Customer List

Table 75. Global Metabotropic Glutamate Receptor 2 Sales Forecast by Region (2023-2028) & (K Pcs)

Table 76. Global Metabotropic Glutamate Receptor 2 Sales Market Forecast by Region

Table 77. Global Metabotropic Glutamate Receptor 2 Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Metabotropic Glutamate Receptor 2 Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Metabotropic Glutamate Receptor 2 Sales Forecast by Country (2023-2028) & (K Pcs)

Table 80. Americas Metabotropic Glutamate Receptor 2 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Metabotropic Glutamate Receptor 2 Sales Forecast by Region (2023-2028) & (K Pcs)

Table 82. APAC Metabotropic Glutamate Receptor 2 Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Metabotropic Glutamate Receptor 2 Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Europe Metabotropic Glutamate Receptor 2 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Middle East & Africa Metabotropic Glutamate Receptor 2 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Metabotropic Glutamate Receptor 2 Sales Forecast by Type (2023-2028) & (K Pcs)

Table 88. Global Metabotropic Glutamate Receptor 2 Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Metabotropic Glutamate Receptor 2 Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Metabotropic Glutamate Receptor 2 Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Metabotropic Glutamate Receptor 2 Sales Forecast by Application (2023-2028) & (K Pcs)

Table 92. Global Metabotropic Glutamate Receptor 2 Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Metabotropic Glutamate Receptor 2 Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Metabotropic Glutamate Receptor 2 Revenue Market Share Forecast by Application (2023-2028)

Table 95. Addex Therapeutics Ltd Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors

Table 96. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Product Offered

Table 97. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 98. Addex Therapeutics Ltd Main Business

Table 99. Addex Therapeutics Ltd Latest Developments

Table 100. Bristol-Myers Squibb Company Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors

Table 101. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Product Offered

Table 102. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 103. Bristol-Myers Squibb Company Main Business

Table 104. Bristol-Myers Squibb Company Latest Developments

Table 105. Denovo Biopharma LLC Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors

Table 106. Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Product Offered

Table 107. Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 108. Denovo Biopharma LLC Main Business

Table 109. Denovo Biopharma LLC Latest Developments

Table 110. Domain Therapeutics SA Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors

Table 111. Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Product Offered

Table 112. Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 113. Domain Therapeutics SA Main Business

Table 114. Domain Therapeutics SA Latest Developments

Table 115. Eli Lilly and Company Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors

Table 116. Eli Lilly and Company Metabotropic Glutamate Receptor 2 Product Offered

Table 117. Eli Lilly and Company Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 118. Eli Lilly and Company Main Business

Table 119. Eli Lilly and Company Latest Developments

Table 120. Johnson & Johnson Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors

Table 121. Johnson & Johnson Metabotropic Glutamate Receptor 2 Product Offered

Table 122. Johnson & Johnson Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 123. Johnson & Johnson Main Business

Table 124. Johnson & Johnson Latest Developments

Table 125. Merck & Co Inc Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors

Table 126. Merck & Co Inc Metabotropic Glutamate Receptor 2 Product Offered

Table 127. Merck & Co Inc Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 128. Merck & Co Inc Main Business

Table 129. Merck & Co Inc Latest Developments

List of Figures

Figure 1. Picture of Metabotropic Glutamate Receptor 2

Figure 2. Metabotropic Glutamate Receptor 2 Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Metabotropic Glutamate Receptor 2 Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Metabotropic Glutamate Receptor 2 Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Metabotropic Glutamate Receptor 2 Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of LY-2607540

Figure 10. Product Picture of BMT-133218

Figure 11. Product Picture of DT-2442

Figure 12. Product Picture of JNJ-40411813

Figure 13. Product Picture of Others

Figure 14. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type in 2021

Figure 15. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Type (2017-2022)

Figure 16. Metabotropic Glutamate Receptor 2 Consumed in Anxiety Disorders

Figure 17. Global Metabotropic Glutamate Receptor 2 Market: Anxiety Disorders (2017-2022) & (K Pcs)

Figure 18. Metabotropic Glutamate Receptor 2 Consumed in Depression

Figure 19. Global Metabotropic Glutamate Receptor 2 Market: Depression (2017-2022) & (K Pcs)

Figure 20. Metabotropic Glutamate Receptor 2 Consumed in Schizophrenia

Figure 21. Global Metabotropic Glutamate Receptor 2 Market: Schizophrenia (2017-2022) & (K Pcs)

Figure 22. Metabotropic Glutamate Receptor 2 Consumed in Chronic Pain

Figure 23. Global Metabotropic Glutamate Receptor 2 Market: Chronic Pain (2017-2022) & (K Pcs)

Figure 24. Metabotropic Glutamate Receptor 2 Consumed in Others

Figure 25. Global Metabotropic Glutamate Receptor 2 Market: Others (2017-2022) & (K Pcs)

Figure 26. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2017-2022)

Figure 27. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Application in 2021

Figure 28. Metabotropic Glutamate Receptor 2 Revenue Market by Company in 2021 ($ Million)

Figure 29. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Company in 2021

Figure 30. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Geographic Region (2017-2022)

Figure 31. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Geographic Region in 2021

Figure 32. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Region (2017-2022)

Figure 33. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Country/Region in 2021

Figure 34. Americas Metabotropic Glutamate Receptor 2 Sales 2017-2022 (K Pcs)

Figure 35. Americas Metabotropic Glutamate Receptor 2 Revenue 2017-2022 ($ Millions)

Figure 36. APAC Metabotropic Glutamate Receptor 2 Sales 2017-2022 (K Pcs)

Figure 37. APAC Metabotropic Glutamate Receptor 2 Revenue 2017-2022 ($ Millions)

Figure 38. Europe Metabotropic Glutamate Receptor 2 Sales 2017-2022 (K Pcs)

Figure 39. Europe Metabotropic Glutamate Receptor 2 Revenue 2017-2022 ($ Millions)

Figure 40. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales 2017-2022 (K Pcs)

Figure 41. Middle East & Africa Metabotropic Glutamate Receptor 2 Revenue 2017-2022 ($ Millions)

Figure 42. Americas Metabotropic Glutamate Receptor 2 Sales Market Share by Country in 2021

Figure 43. Americas Metabotropic Glutamate Receptor 2 Revenue Market Share by Country in 2021

Figure 44. United States Metabotropic Glutamate Receptor 2 Revenue Growth 2017-2022 ($ Millions)

Figure 45. Canada Metabotropic Glutamate Receptor 2 Revenue Growth 2017-2022 ($ Millions)

Figure 46. Mexico Metabotropic Glutamate Receptor 2 Revenue Growth 2017-2022 ($ Millions)

Figure 47. Brazil Metabotropic Glutamate Receptor 2 Revenue Growth 2017-2022 ($ Millions)

Figure 48. APAC Metabotropic Glutamate Receptor 2 Sales Market Share by Region in 2021

Figure 49. APAC Metabotropic Glutamate Receptor 2 Revenue Market Share by Regions in 2021

Figure 50. China Metabotropic Glutamate Receptor 2 Revenue Growth 2017-2022 ($ Millions)

Figure 51. Japan Metabotropic Glutamate Receptor 2 Revenue Growth 2017-2022 ($ Millions)

Figure 52. South Korea Metabotropic Glutamate Receptor 2 Revenue Growth 2017-2022 ($ Millions)

Figure 53. Southeast Asia Metabotropic Glutamate Receptor 2 Revenue Growth 2017-2022 ($ Millions)

Figure 54. India Metabotropic Glutamate Receptor 2 Revenue Growth 2017-2022 ($ Millions)

Figure 55. Australia Metabotropic Glutamate Receptor 2 Revenue Growth 2017-2022 ($ Millions)

Figure 56. Europe Metabotropic Glutamate Receptor 2 Sales Market Share by Country in 2021

Figure 57. Europe Metabotropic Glutamate Receptor 2 Revenue Market Share by Country in 2021

Figure 58. Germany Metabotropic Glutamate Receptor 2 Revenue Growth 2017-2022 ($ Millions)

Figure 59. France Metabotropic Glutamate Receptor 2 Revenue Growth 2017-2022 ($ Millions)

Figure 60. UK Metabotropic Glutamate Receptor 2 Revenue Growth 2017-2022 ($ Millions)

Figure 61. Italy Metabotropic Glutamate Receptor 2 Revenue Growth 2017-2022 ($ Millions)

Figure 62. Russia Metabotropic Glutamate Receptor 2 Revenue Growth 2017-2022 ($ Millions)

Figure 63. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales Market Share by Country in 2021

Figure 64. Middle East & Africa Metabotropic Glutamate Receptor 2 Revenue Market Share by Country in 2021

Figure 65. Egypt Metabotropic Glutamate Receptor 2 Revenue Growth 2017-2022 ($ Millions)

Figure 66. South Africa Metabotropic Glutamate Receptor 2 Revenue Growth 2017-2022 ($ Millions)

Figure 67. Israel Metabotropic Glutamate Receptor 2 Revenue Growth 2017-2022 ($ Millions)

Figure 68. Turkey Metabotropic Glutamate Receptor 2 Revenue Growth 2017-2022 ($ Millions)

Figure 69. GCC Country Metabotropic Glutamate Receptor 2 Revenue Growth 2017-2022 ($ Millions)

Figure 70. Manufacturing Cost Structure Analysis of Metabotropic Glutamate Receptor 2 in 2021

Figure 71. Manufacturing Process Analysis of Metabotropic Glutamate Receptor 2

Figure 72. Industry Chain Structure of Metabotropic Glutamate Receptor 2

Figure 73. Channels of Distribution

Figure 74. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390